Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Jul;64(1):90–92. doi: 10.1038/bjc.1991.246

Antitumour response and nephrotoxicity following intraperitoneal administration of a slow release formulation of cisplatin to rats bearing cancers restricted to the peritoneal cavity.

G Los 1, W Kop 1, M J Deurloo 1
PMCID: PMC1977314  PMID: 1854631

Full text

PDF
90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell A. B., Kalman S. M., Jacobs C. Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity. Cancer Treat Rep. 1983 Feb;67(2):169–172. [PubMed] [Google Scholar]
  2. Daugaard G., Abildgaard U. Cisplatin nephrotoxicity. A review. Cancer Chemother Pharmacol. 1989;25(1):1–9. doi: 10.1007/BF00694330. [DOI] [PubMed] [Google Scholar]
  3. Daugaard G., Strandgaard S., Holstein-Rathlou N. H., Frederiksen P. L., Svendsen U. G., Munck O., Leyssac P. P. The renal handling of sodium and water is not affected by the standard-dose cisplatin treatment for testicular cancer. Scand J Clin Lab Invest. 1987 Sep;47(5):455–459. [PubMed] [Google Scholar]
  4. Dunnick N. R., Jones R. B., Doppman J. L., Speyer J., Myers C. E. Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics. AJR Am J Roentgenol. 1979 Aug;133(2):221–223. doi: 10.2214/ajr.133.2.221. [DOI] [PubMed] [Google Scholar]
  5. Higby D. J., Wallace H. J., Jr, Holland J. F. Cis-diamminedichloroplatinum (NSC-119875): a phase I study. Cancer Chemother Rep. 1973 Nov-Dec;57(4):459–463. [PubMed] [Google Scholar]
  6. Lokich J. J. Phase I study of cis-diamminedichloroplatinum(II) administered as a constant 5-day infusion. Cancer Treat Rep. 1980 Aug-Sep;64(8-9):905–908. [PubMed] [Google Scholar]
  7. Los G., Mutsaers P. H., van der Vijgh W. J., Baldew G. S., de Graaf P. W., McVie J. G. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res. 1989 Jun 15;49(12):3380–3384. [PubMed] [Google Scholar]
  8. Los G., Ruevekamp M., Bosnie N., De Graaf P. W., McVie J. G. Intraperitoneal tumor growth and chemotherapy in a rat model. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1857–1866. doi: 10.1016/0277-5379(89)90359-3. [DOI] [PubMed] [Google Scholar]
  9. Madias N. E., Harrington J. T. Platinum nephrotoxicity. Am J Med. 1978 Aug;65(2):307–314. doi: 10.1016/0002-9343(78)90825-2. [DOI] [PubMed] [Google Scholar]
  10. Rosenshein N., Blake D., McIntyre P. A., Parmley T., Natarajan T. K., Dvornicky J., Nickoloff E. The effect of volume on the distribution of substances instilled into the peritoneal cavity. Gynecol Oncol. 1978 Feb;6(1):106–110. doi: 10.1016/0090-8258(78)90010-0. [DOI] [PubMed] [Google Scholar]
  11. Vermorken J. B., van der Vijgh W. J., Klein I., Gall H. E., Pinedo H. M. Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications. Eur J Cancer Clin Oncol. 1982 Nov;18(11):1069–1074. doi: 10.1016/0277-5379(82)90085-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES